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Abstract: Coronary computed tomographic angiography (CCTA) is a rapidly evolving test 
for diagnosis of coronary artery disease. Although invasive coronary angiography is the 
gold standard for coronary artery disease (CAD), CCTA is an excellent noninvasive tool for 
evaluation of chest pain. There is ample evidence to support the cost-effective use of CCTA in 
the early triage process of patients presenting with chest pain in the emergency room. CCTA 
plays a critical role in the diagnosis of chest pain etiology as one of potentially fatal conditions, 
aortic dissection, pulmonary embolism, and myocardial infarction. This ‘triple rule out’ protocol 
is becoming an increasingly practicable and popular diagnostic tool in ERs across the country. 
In addition to a quick triage of chest pain patients, it may improve quality of care, decrease 
cost, and prevent medico-legal risk for missing potentially lethal conditions presenting as chest 
pain. CCTA is also helpful in the detection of subclinical and vulnerable coronary plaques. The 
major limitations for wide spread acceptance of this test include radiation exposure, motion 
artifacts, and its suboptimal imaging with increased body mass index.
Keywords: calcium scoring, computed tomography, coronary artery disease (CAD), 
angiography, coronary CTA, chest pain, community hospitals, emergency room, pulmonary 
embolism, aortic dissection
Background
Coronary computer tomographic angiography (CCTA) has been playing an incremen-
tal role in the diagnosis of coronary artery disease (CAD). CCTA has been especially 
useful in the triage of patients with acute chest pain. These patients are frequent visitors 
of emergency rooms posing an immediate diagnostic and therapeutic challenge. Chest 
pain patients present with potentially fatal conditions such as acute coronary syndrome 
(ACS), aortic dissection (AD), and pulmonary embolism (PE). Efficient evaluation of these 
chest pain patients with CCTA prevents complications, death, and disability. Evaluation 
and triage of more than 6,392,000 patients1 presenting with chest pain nationwide poses 
a significant challenge to the health care system and CCTA evaluation of these patients 
may alleviate this challenge and save not only lives, but also the cost and complications 
of invasive procedures such as cardiac catheterization. This becomes an important issue 
in small community hospitals where limited resources have to be efficiently used.
Evolution of CCTA
Since the pioneering work of Sir Godfrey N Hounsfield in 1972, CT technology has 
developed at a fast pace. Electron beam computed tomography (EBCT), otherwise 
called ultrafast CT or cine CT, was first introduced in 1980, followed by the 4-slice Vascular Health and Risk Management 2010:6 308
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CT in the year 2000, 16-slice in 2002, and 64-slice in 2004. 
Initially cardiac CT, performed on 4-slice multidetec-
tor computed tomography (MDCT), examinations were 
confined to the evaluation of only proximal coronary arteries. 
There was poor spatial and temporal resolution with long 
acquisition time requiring intolerably long breath hold peri-
ods. This was revolutionized by the 16-slice MDCT, where 
for the first time a complete examination of coronary arteries 
was performed with a breath hold of just 20 seconds. Then 
the 64-slice MDCT scan became widely available. These 
scanners have much higher spatial and temporal resolution 
with a scan time of 12–15 seconds compared to 20 seconds 
with the 16-slice coronary CTA. This enables medical staff to 
perform a rapid screen for CAD in community hospitals.
The CT has undergone a dramatic improvement in 
imaging with evolution from a single-slice/detector to 
a multi-slice/detector leading to the commonly used 
terminology, MDCT or multi-slice computed tomography 
(MSCT). In this manuscript, for coronary imaging, the term 
CCTA will be used interchangeably with MDCT or MSCT.
This modality employs a rotating source of X-rays with 
circular and stationary detector arrays. X-ray photons are 
generated within a specialized X-ray tube mounted on 
a rotating gantry which pass through the patient’s body 
and are detected by fixed rows of detector arrays, thus 
producing images of coronary arteries in seconds after 
the patient is scanned with current scanners as shown in 
Figures 1 and 2.
Most recently, 256-slice and 320-slice scanners have been 
introduced. With this new generation of scanners, there has 
been a progressive improvement in spatial and temporal resolu-
tion. Similarly, dual-source CT (DSCT) scanners incorporate 
two tubes and two corresponding detectors which offer con-
siderable advantage with temporal resolution as low as 83 ms,2 
leading to elimination of a majority of artifacts.3 Its role is also 
evolving in the detection of subclinical atherosclerosis and 
vulnerable plaque, the most common cause of ACS.
Scope of CCTA in patients  
with chest pain
Chest pain is a frequent complaint among emergency room (ER) 
patients in this country. In many of these patients, basic evalua-
tion by the ER physician including history, physical examination, 
electrocardiography (ECG), and initial cardiac biomarkers does 
not exhibit evidence of active myocardial ischemia. Inappropriate 
numbers of these patients are admitted to hospitals with suspected 
ACS leading to long hospital stays especially over the weekends. 
Extensive efforts have been made over the past decade to create 
chest pain centers with protocols in place for early detection, risk 
stratification, and timely discharge of chest pain patients. While 
this concept is helpful, there has been a continued practice of 
expensive evaluation and prolonged hospitalization for a majority 
of these patients presenting with chest pain.
More than 50% of ER admissions to the hospital are for 
observation to collect preliminary data to exclude ACS, PE, 
and AD. Unfortunately, positive yield of this large number 
Figure 1 Illustration of thin MIP reconstruction of left coronary artery. 
Note: Similarity of CCTA image to an angiographic appearance. Figure 2 Illustration of soft and calcified plaque in proximal and mid LAD.Vascular Health and Risk Management 2010:6 309
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of admissions is as low as 2%–5%,4,5 and a majority of these 
patients (55%) are found to have noncardiac pathology.6 Con-
versely, 2% of patients with chest pain are discharged inap-
propriately with missed diagnosis of ACS, PE, and AD.6–8
The underlying reason for this practice is to exclude any 
potentially fatal etiologies of chest pain such as MI, PE, and 
AD. Therefore, physicians are reluctant to send these patients 
home from the ER because of the risk of 2% missed diagnosis 
of acute myocardial infarction (AMI)6,9,10 in these patients. 
This type of ER practice is fraught with a tremendous cost of 
more than 12 billion dollars a year.11 In community hospitals, 
the wide spread availability of CCTA as an important test 
may expedite early diagnosis and discharge of chest pain 
patients. Furthermore, unnecessary transfer of some of 
these patients to tertiary care hospitals may be avoided and 
significant health care savings may be achieved.
The gold standard for visualization of coronary arteries 
has been invasive coronary angiography. The use of this 
technique has increased many fold over the past three decades 
leading to exorbitant cost and inconvenience to the patients.12 
Furthermore, it is plagued with the issue of operator dependent 
variability in coronary lesion assessment for percent stenosis.13 
Consequently, there has been an increasing interest to develop 
a less invasive and cost effective technique for evaluation of 
coronary arteries. Out of many exciting technologies, CCTA 
is emerging as the most promising tool for the diagnosis of 
CAD, while excluding other potentially fatal conditions such as 
AD (Figure 3) and PE (Figure 4) which may also present with 
chest pain. Therefore, there is a great need for a noninvasive 
tool such as CCTA for definitive early diagnosis of the cause 
of chest pain in the ER.
Current indications
There is a definite role for CCTA in patients with chest pain 
who have low to intermediate probability of CAD and other 
cardiac conditions as listed in Table 1. There has been an 
emerging role for this test in the ‘triple rule out’ protocol for 
chest pain patients in the ER.
Emerging indications
The crucial role of CCTA for evaluation of chest pain and 
early triage of patients in the ER is evolving very fast. The 
feature of three dimensional volumetric acquisitions virtually 
allows unlimited views for image projection after processing. 
There has been intense interest in ‘triple rule out’ protocol for 
chest pain by a single acquisition that results in simultaneous 
opacification of coronary arteries, aorta, and arterial phase 
opacification of pulmonary arteries. This examination may 
need 110 cc of contrast, a specialized post-processing with 
routine reconstruction for coronaries, wide field of view 
(FOV) coronal reconstruction of lungs, and oblique sagittal 
reconstruction for thoracic aorta. The major disadvantage 
of ‘triple rule out’ protocol is an increase in the radiation 
dose due to the large area of coverage and an increase in 
contrast use. CCTA has the advantage of faster acquisition 
in a single breath hold with excellent imaging resolution. 
Figure 4 Patient presenting with acute chest pain; CCTA image showing large right 
pulmonary artery embolism.
Figure 3 Patient presenting with acute chest pain; CCTA image showing large aortic 
root dissection.Vascular Health and Risk Management 2010:6 310
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More importantly, widespread availability makes its usage 
feasible in community hospitals.
Triage tools for chest pain
There are several tools available in the ER for early triage 
of chest pain patients. The basic practice is to obtain 
history and physical examination (H&P) with cardiac 
markers, chest X-ray, and ECG. H&P is a crucial part, and 
therefore a majority of ERs have developed protocols to 
elicit all the pertinent history and physical findings. This 
basic practice helps to risk stratify the patients by TIMI 
score as illustrated in Table 2. The majority of these low to 
intermediate patients,14 with TIMI score less than three, do 
not have CAD, and due to very low yield in this group they 
end up getting admitted to the hospitals for observation and 
sequential cardiac biomarkers assessment prior to definite 
evaluation with a stress test and/or cardiac catheterization. 
Cardiac biomarkers are the standard of care and typically 
take 6–12 hours to become positive in the blood test and 
therefore many patients with active ischemia and/or injury 
may be missed by cardiac biomarkers criteria. CCTA in the 
ER as a triage tool provides a new paradigm shift, and its 
role is clearly and rapidly emerging.
There are many objective tests used in setting of the 
ER such as echocardiography, nuclear studies, magnetic 
resonance imaging (MRI), and coronary artery calcium 
(CAC) scoring. Echocardiography has a very limited role in 
chest pain evaluation due to its limited sensitivity for AMI 
in patients with ACS when pain has already resolved.15,16 
In late 1990, many chest pain centers developed the use 
of the radionuclide stress test using single photo emission 
computed tomography (SPECT) to help risk stratification and 
early discharge of chest pain patients in the ER. Myocardial 
imaging studies with Tc-99m-based radioisotope have shown 
an excellent negative predictive value (NPV) as a screening 
test,17,18 though the positive predictive value may be limited 
due to suboptimal imaging resolution and artifacts. MRI 
has the ability to diagnose CAD and other potentially fatal 
conditions such as PE and AD.19,20 However, its use as a 
first line test is limited by multiple factors such as technical 
expertise, physician availability on site, and contraindications 
to MRI due to metallic implants.
Absence of CAC or minimal CAC predicted a very 
low incidence of future cardiac events in asymptomatic 
patients21–24 and symptomatic patients undergoing coronary 
angiography.6,9,10 Several studies have shown the value of 
CAC in ER patients with negative ECG and cardiac enzymes 
as a triage tool with a very high negative predictive value 
(NPV).25,26 Georgiou et al performed EBCT in 192 patients 
with chest pain and had an average follow up of 50 ± 10 
months. Among this cohort, 30% showed a graded relation-
ship between all cardiac events and CAC score.26 This study 
showed CAC as a triage test with sensitivity of 97% and NPV 
of 99%. Patients without CAC (CAC score = 0) had 0.6/year 
future cardiovascular events. Recent studies have shown that 
CAC may be a useful tool in the ER for risk stratification of 
patients with ACS. Several other studies have demonstrated a 
significant correlation between CAC and the overall coronary 
artery atherosclerotic plaque burden.27–31 These studies have 
shown high sensitivity 95% and high NPV of 95%.
CCTA as a triage tool
CCTA may become an attractive option as a triage tool in 
the ER due to its widespread availability and noninvasive 
Table 1 Indications for CCTA
Chest pain syndrome:
  • Intermediate pre-test probability
  • Uninterpretable ECG
  • Patients unable to exercise
  • Detection of CAD with prior equivocal or uninterpretable test
Evaluation of CAD in new onset CHF
Noninvasive evaluation of LIMA prior to redo CABG
Assessment of complex congenital heart disease
Evaluation of cardiac masses
Evaluation of pericardial conditions
Patients with technically limited ECHO, MRI or TEE
Evaluation of pulmonary veins prior to AF ablation
  Evaluation of coronary vein mapping prior to biventricular pacemaker 
insertion
  Evaluation of suspected aortic dissection and/or thoracic aortic  
aneurysm
Evaluation of suspected pulmonary embolism
Table 2 TIMI score
TIMI SCORE: (Assigned 1 point each)
Medical history factors:
  Age 65
  Known CAD with 50% stenosis
    Three or more coronary risk factors 
(Positive FH, HTN, Hyperlipidemia, DM, Smoking)
  Aspirin use in past 7 days
Clinical presentation factors:
  Two or more angina events in 24 hours
  Increase in cardiac markers
  ST segment deviation
Abbreviations: FH, family history; HTN, hypertension; DM, diabetes mellitus.Vascular Health and Risk Management 2010:6 311
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approach. Several CCTA studies have shown an excellent 
correlation of CCTA with coronary angiography with 
sensitivities ranging from 92%–95% and NPV of 97%–98% 
for the diagnosis of significant CAD.32–36 Two published 
meta-analyses have shown excellent sensitivity and 
specificity of CCTA for CAD as compared to coronary 
angiography.37,38 Moreover, CCTA has shown a promise in 
detecting noncalcified plaque,39 and an evaluation global left 
ventricular function comparable to MRI.40
As early as 1996, many studies have investigated its use 
as a triage tool in ER patients with chest pain, negative ECG, 
and cardiac enzymes.41 The NPV of CCTA in such patients 
has been reported to be 97%–100%. Gallagher et al reported 
their experience with CCTA in low risk patients with negative 
ECG and cardiac markers in the ER42 where all patients had 
nuclear sestamibi scan and CCTA. This study reflected the 
accuracy of CCTA comparable to well established nuclear 
tests in these low risk patients.
Initial evaluation of ACS patients in the ER was 
performed using 16-slice CCTA by Kimura et al.43 A total 
of 74 consecutive patients with ACS (non-ST elevation) 
patients with ACS/non-ST elevation myocardial infarction 
(NSTEMI) underwent CCTA within 24 hours. Significant 
coronary lesions were correctly identified in 56 out of 
57 patients. Similarly, 11 out of 13 patients without 
significant disease were correctly diagnosed. Lida et al 
have reported similar findings in 28 patients with ACS.44 
Subsequently, there have been many studies using 64-slice 
CCTA. A single center experience in 70 patients using 
64-slice CCTA showed sensitivity of 95%, specificity of 
90%, and NPV of 93%.36
A recent study, Rule Out Myocardial Infarction using 
Computer Assisted Tomography (ROMICAT)45 evaluated 
the value of CCTA in the triage of ER patients with ACS. 
This was an observational cohort study of 368 patients 
presenting to the ER with chest pain, normal troponin, 
and nonischemic ECG. 64-slice CCTA was performed in 
these patients before index hospitalization and results were 
not disclosed to treating physicians. End points were ACS 
during index hospitalization and major adverse cardiac events 
(MACE) in six months. Among this cohort, 50% of patients 
had no CAD on CCTA, 31% had nonobstructive CAD, 
and only 19% had more than 50% stenosis or inconclusive 
considered as positive study. Moreover, door to CCTA was 
only 16 minutes in ROMICAT compared to 40.5 hours of an 
average hospital stay.46 Given these findings, a large number 
of patients did not need hospitalization and could have been 
triaged in the ER by CCTA.
This study and several other studies may support the 
use of CCTA in the ER. The ROMICAT study45 also 
demonstrated sensitivity and NPV of 100% for ACS. 
Several other studies have showed higher sensitivity, 
specificity, and NPV in evaluation of ACS in the ER.47–50 
A recent presentation at the American Heart scientific 
session (2009)51 looked at the role of CCTA as a triage tool 
in the ER in patients presenting with chest pain in Computed 
Tomography for Systematic Triage of Acute chest pain 
and Treatment (CT-STAT) trial. In this trial, investigators 
included 749 patients presenting to the ER with acute chest 
pain within 12 hours of onset of symptoms with normal 
ECG and normal cardiac biomarkers. These patients were 
randomized to the CCTA arm or to the conventional 
standard of care treatment arm with myocardial perfusion 
imaging to expedite early diagnosis. In the CCTA arm, 
82.3% had no significant disease leading to early discharge. 
Among the cohort undergoing conventional management, 
90% had a normal myocardial perfusion study as part of 
standard work up. Early diagnosis (door to diagnosis) 
was much faster in the CCTA arm with mean diagnosis 
time 2.9 hours in the CCTA arm compared to 6.2 hours 
in the conventional standard of care arm with myocardial 
perfusion imaging. Moreover, the radiation exposure in 
the CCTA arm was 10.8 mSv compared to 15 mSv in 
the conventional arm. Overall cost in the CCTA arm was 
$2,138 compared to $3,458 in the conventional arm. This 
trial demonstrated the feasibility of effective triage of a 
chest pain patient with early door to diagnosis leading to 
early discharge with lesser radiation exposure. CCTA has 
great promise in detection of CAD in patients with a low 
pre-test probability and these constitute a large number of 
patients coming to the ER of community hospitals.
It may also be very useful in patients with atypical 
chest pain with left bundle branch block (LBBB) where 
frequent coronary angiography is performed to exclude 
CAD. Caussin et al52 evaluated the role of 64-slice CCTA 
in 66 patients with LBBB and found a sensitivity of 97%, 
specificity of 95%, and NPV of 97% for detection of CAD 
with 50% stenosis. Similarly, it showed a 100% sensitivity 
and 92% specificity for detection of CAD in subsets of aortic 
stenosis (AS).53 Frequently, these patients with equivocal 
stress test or new onset of congestive heart failure (CHF) are 
admitted to the hospital for exclusion of significant CAD. 
CCTA combined with myocardial perfusion imaging has 
been increasingly used in intermediate risk patients. This 
allows simultaneous functional and anatomic assessment 
of CAD.54 Its role in assessing myocardial viability is being Vascular Health and Risk Management 2010:6 312
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investigated to identify acute and old MI.55 With its spatial 
resolution, CCTA’s emerging role is being explored in the 
assessment of aortic valve anatomy and pathology.56,57 Other 
applications of CCTA include evaluation of pericardial and 
myocardial diseases as listed in Table 1.
Role of CCTA in subclinical 
atherosclerosis (SCA)
A recent study by Pundzuite et al showed that nonobstructive 
coronary disease on CCTA can lead to higher cardiovascular 
events as compared to patients without atherosclerotic 
plaque.58 Therefore, detection of sub-clinical atherosclerosis 
may lead to aggressive risk factor modification and a 
reduction in CAD burden of the general population. While 
this approach may save lives and money in the long term, 
immediate concerns are the expense of CCTA and the 
radiation issue. Meanwhile, CAC appears to be an excellent 
screening test for detection of sub-clinical CAD.
Detection of vulnerable plaque
The detection of vulnerable plaque leading to coronary 
events is of great interest. Detection of asymptomatic CAD 
has been debated since the publication of the Screening for 
Heart Attack Prevention and Education (SHAPE) Task Force 
report.59 Although invasive coronary angiography can grossly 
identify morphologic features such as luminal thrombosis, 
calcification, and plaque disruption, it fails to delineate 
qualitative features of the plaque predictive of rupture.60 
While calcified plaque may be detected by CAC, the role of 
CCTA is evolving into the evaluation of soft plaque which 
may be the vulnerable plaque.
Small numbers of validation studies have demonstrated 
the accuracy of CCTA for imaging noncalcified plaque with 
sensitivity ranging from 80%–90%.61–65 Certain indicators 
of vulnerable plaque, such as vessel remodeling or a high 
plaque volume noted on CCTA, may help predict ischemic 
events.65,66 Several small studies in ACS have found have 
a higher percentage of noncalcified plaque and positive 
remodeling in patients with ACS compared to stable 
angina.67–69 In most patients, AMI may be the first clinical 
manifestation of sub-clinical plaque rupture or erosion.70
There has been great debate in regard to imaging of this 
vulnerable plaque. Major technologies which can help image 
this plaque include intravascular ultrasound (IVUS), MRI, 
positron emission tomography (PET) imaging, and CCTA or 
MDCT.71 Increased carotid artery intimal thickness noted in 
ultrasound studies has been a marker of cardiovascular and 
cerebral atherosclerosis.72 Molecular imaging techniques 
have used radio-labeled molecules to detect the biological 
activity of plaques such as radioactive-labeled lipoproteins.73 
IVUS of coronary plaques is useful in the evaluation of 
vulnerable plaques. CCTA has also been compared favorably 
with IVUS in the measurement of atherosclerotic plaque and 
lumen area.74 CCTA certainly appears to be promising in the 
evaluation of plaque characteristics and associated arterial 
remodeling.75 Recently a prospective study demonstrated that 
patients with positively remodeled arteries with low attenu-
ation plaques on CT angiography were at a higher risk of 
developing ACS in the subsequent follow up period.76
Radiation issues
With emerging indications of CCTA, there is concern about 
the long term effect of radiation. Current CT scan use for 
various studies is expected to contribute to a large num-
ber of future malignancies and it is estimated that 29,000 
future cancers are possibly related to all CT scans done in 
2007.77 Therefore, any radiation exposure should always 
be a concern for risk. One should familiarize oneself with 
the background radiation and the radiation associated with 
the commonly used tests in cardiology practice78–81 as shown 
in Table 3. Given this carcinogenic potential of radiation, 
health care workers who prescribe this radiation must be 
fully aware of radiation risks. They should have a full 
understanding of effective dose concept which is a standard 
of measure of exposure expressed in millisievert (mSv). 
Effective dose is the sum of weighted equivalent doses in 
all the organs and tissues during a particular scan. Due to 
higher doses delivered to lungs and female breast in CCTA, 
there is a higher carcinogenic effect on these organs. This 
risk is higher in younger patients and more in women than 
Table 3 Dose of radiation in different cardiac procedures
Examination Mean effective dose
Background radiation 3 mSv/year
Chest X-ray 0.1 mSv
Calcium scoring 2 mSv
Chest CT 5–7 mSv
CT abdomen and Pelvis 8–11 mSv
Coronary angiography 5.6 mSv
PTCA 6.9 mSv
Coronary angiography with PTCA 9.3 mSv
Coronary Angiography + PTCA + Stent 13 mSv
SPECT-MIBI 11 mSv
SPECT-Thallium 25 mSv
Coronary CTA (males) 6.7–10.9 mSv
Coronary CTA (Females) 8.1–13.0 mSvVascular Health and Risk Management 2010:6 313
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in men. It is conceivable that in the near future patients may 
carry an “imaging card” reflecting the cumulative dose of 
radiation received by an individual patient which may be a 
factor to consider while ordering additional imaging studies 
requiring more radiation exposure.
Better scanners and software have contributed significantly 
to reduction in radiation exposure. Many dose reducing 
technical advances are available on 64-slice scans. These 
include cardiac filter modes, bowtie filters, and newer 
protocols such as ECG-triggered dose modulation and 
prospective gating. Quality control of scanners regarding 
the radiation issue is also very important. Recording of 
radiation dose for every patient in mSv should be mandatory 
and if there is a significant deviation from the published 
data, individual protocols in a given CCTA program should 
be reviewed. Government regulations via Environmental 
Protection Agency (EPA) require monitoring of credentials 
of ordering personnel, justified indications, and regular equip-
ment check for minimum exposure and stringent indications 
for pregnant patients. For example, federal standards state 
that the radiation dose to an unborn child cannot exceed 
5 mSv over a nine-month period. This is because unborn 
children have rapidly growing cells and are therefore most 
sensitive to radiation.
Preparation for CCTA program
Meticulous preparation of the patient for CCTA is the key 
to obtaining a diagnostic image which would aid the man-
agement of patients with acute or chronic cardiac problems. 
Guidelines are listed in Table 4 and these may vary depending 
upon capabilities of the scanner such as single source or dual 
sources.82 As part of starting a CCTA program appropriate 
guidelines for documentation of competence83 should be 
delineated as a part of a quality control program. A scanner 
must be staffed by highly skilled and qualified technologists. 
Staff and physicians should be knowledgeable in the issues of 
radiation exposure, CT scan collimation, temporal resolution, 
and spatial resolution. Achieving a target heart rate of 60–70 
is important for adequate images by a single source system.84 
Pre-scan use of nitroglycerine is helpful for visualization of 
distal coronary arteries due to a 20% increase in the resultant 
diameter of coronary arteries.85
Quality control during acquisition of images is very 
important and staff should be knowledgeable of all the 
technical parameters such as table speed (pitch), window 
setting, level setting, reconstructions, post-processing, 
and image manipulations. A thorough understanding of 
contrast injection methods, adverse reactions, and contrast 
kinetics is critical. It is very important to understand how to 
overcome challenges of contrast-enhanced imaging of the 
left heart and surrounding structures. In high risk patients an 
iso-osmolar contrast such as Visipaque® should be selected 
as its viscosity is the same as blood, 290 m osmols/kg H20. 
All other contrast media have an osmolality of more than 
600 m osmols/kg H20.
Instruction and education of the patient regarding CCTA 
is crucial in obtaining adequate images. Occasionally, simple 
obstacles such as the patient’s inability to raise the arm above 
the head to move arms out the FOV or inability to hold 
their breath may be a relative contraindication for coronary 
imaging by CCTA. It is also crucial to exclude patients with 
known levels of high CAC score as CCTA images may be 
nonevaluable.86
Conclusion
The revolution of noninvasive imaging of the heart has 
taken a giant leap forward with widespread availability of 
the 64-slice CT, and now 256 and 320-slice CT scanners. 
The resultant superior spatial resolution, with improved 
temporal resolution with faster gantry rotation and dual 
source heads, offer the potential for remarkable improvement 
in sensitivity, specificity, and NPV in the diagnosis of CAD. 
Future generation scanners may provide an opportunity for 
first line imaging of CAD. Thus in patients presenting with 
chest pain, CCTA may be able to assess coronary lumen of 
calcified or noncalcified plaque and further evaluate other 
life threatening conditions such as AD and PE. The ‘triple 
rule out’ examination holds promise for revolutionizing the 
imaging of patients with acute chest pain in the ER. With 
wide spread availability in community hospitals, CCTA is 
likely to be embraced as the noninvasive triage tool of choice 
Table 4 General guidelines
Screen for contraindications
ECG rhythm and baseline HR
Assess renal function
Instructions and education
Proper placement of ECG leads
Administer b Blockers: Individualize
  • Oral 50–100 mg one hour before procedure
  • IV-5 mg metoprolol prior to scan and practice breath holding
  • Monitor HR during breath hold
  • IV Metoprolol 5 mg q5 min x5 doses to target HR
  • Calcium channel blocker if b-Blockers CI
Premedicate with S/L 0.4–0.8 mg NTG
Scan the patientVascular Health and Risk Management 2010:6 314
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in the ER. Furthermore, a significant improvement in quality 
of care, cost-effectiveness, and medico-legal liability may 
be accomplished with future CCTA use in the ER. The key 
to implementation of such CCTA programs will be ‘central 
reading stations’ for expert reading and advice to the ER 
physicians, available 24 hours a day, year round for all the 
remote community hospitals just like night hawk radiology 
(Teleradiology).
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